fbpx

Policy Priority: Choice and Access to Medications

Asthma Canada believes that all Canadians living with asthma should have equitable and timely access to prescription medications based on the best possible health outcomes rather than ability to pay. Asthma Canada supports the Government’s commitment to reduce costs and improve access to necessary prescription medications. We continue to advocate for the needs of the Canadian asthma community, calling for lower drug costs through national pharmacare while working to protect patient access to innovative medicines in our country.

We also continue to raise awareness about the importance of choice and innovative medicines for the asthma community. We provide input to the federal government through patient evidence submissions on new treatment options and through submission to the Patented Medicine Prices Review Board (PMPRB).

Access to Medication Campaign

Canada is the only developed country in the world which provides universal healthcare but does not cover the cost of prescribed medications. The economic burden of having to pay for prescriptions out-of-pocket is unsustainable and unfairly targets those who may already be struggling. The asthma community is particularly at risk.

Many Canadians joined Asthma Canada’s efforts to demand universal coverage of prescription medications by sending letters to their government representatives explaining how a lack of access to prescription medication impacts them and their loved ones.

Thanks to you, our voices are being heard.

We applaud the Federal government’s support for the establishment of the Canadian Drug Agency which will oversee the development of a new national formulary of prescribed drugs and provide additional support for Canadians with rare diseases. We look forward to integrating the perspectives of patients and the health charity sector as we work with the Federal Government to implement these investments.

We would like to thank the asthma community for helping put pharmacare on the map as a political priority. Thank you for sharing your stories and experiences; for writing to your elected representatives through our letter-writing campaign; and for joining Asthma Canada as we went to Parliament Hill and met with countless policy makers to reinforce our demand for equitable access to medication.

As we move ahead, it will be essential to ensure that we, the asthma community and the patient community at large, continue this momentum and continue to speak out and make ourselves heard.

We must ensure that pharmacare becomes a commitment across party lines and remains a key political priority regardless of election outcomes. We invite you to join us as we continue our efforts to ensure that all Canadians have equitable access to prescription medication and that patient choice is included in all pharmacare solutions.

Further reading: